Literature DB >> 31661717

Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guérin?

Harry Herr1.   

Abstract

OBJECTIVE: To determine the initial response to intravesical bacillus Calmette-Guérin and the 3-year recurrence rate of high-risk non-muscle-invasive bladder cancer in patients who have asymptomatic bacteriuria.
METHODS: Response and recurrence rates were investigated in 505 patients with high-risk non-muscle-invasive bladder cancer after treatment with induction bacillus Calmette-Guérin (TICE strain) therapy. Initial response was determined after 3 months and patients were followed every 3-6 months for 3 years. Before bacillus Calmette-Guérin and each follow-up cystoscopy, urine cultures were obtained, stratified as no growth, <104, >104 or >105 colony-forming unit/mL. Any degree of bacteriuria on culture was classified as asymptomatic bacteriuria.
RESULTS: Of the 505 cases, 270 (53%) had asymptomatic bacteriuria. A total of 89% of patients with asymptomatic bacteriuria showed a complete response to bacillus Calmette-Guérin versus 76% of uninfected patients (P = 0.001), and 75% of bacteriuric patients survived tumor-free for 3 years versus 65% of uninfected patients.
CONCLUSIONS: Chronic bacteriuria might enhance the response of high-risk non-muscle-invasive bladder cancer to intravesical bacillus Calmette-Guérin and result in longer tumor-free survival than uninfected patients.
© 2019 The Japanese Urological Association.

Entities:  

Keywords:  bacillus Calmette-Guérin; bacteriuria; bladder; cancer; response

Mesh:

Substances:

Year:  2019        PMID: 31661717     DOI: 10.1111/iju.14139

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer.

Authors:  Luca Di Gianfrancesco; Mauro Ragonese; Giuseppe Palermo; Emilio Sacco; Foschi Nazario; PierFrancesco Bassi; Marco Racioppi
Journal:  Curr Urol       Date:  2022-08-27

Review 2.  Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR).

Authors:  Mihaela Georgiana Musat; Christina Soeun Kwon; Elizabeth Masters; Slaven Sikirica; Debduth B Pijush; Anna Forsythe
Journal:  Clinicoecon Outcomes Res       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.